台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國邑*

(6875)
  • 股價
    53.7
  • 漲跌
    ▼0.2
  • 漲幅
    -0.37%
  • 成交量
    94
  • 產業
    上櫃 生技醫療類股
  • 8人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
國邑* (6875)籌碼相關-國泰 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國泰 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/1700.00154.0053.60-1214-0.47%
2024/12/04158.4000.0058.4012290.44%
2024/12/0200.00157.0056.80-1234-0.43%
2024/11/29157.2000.0057.2012440.41%
2024/11/210.257.70656.8857.60-5.8271-2.13%
2024/11/18560.5200.0060.1052721.83%
2024/11/13163.2000.0063.2012820.35%
2024/11/1100.000.364.2064.50-0.3284-0.10%
2024/11/0800.002163.7664.60-21282-7.44%
2024/11/0700.001762.0962.90-17280-6.05%
2024/11/0500.00762.0461.40-7285-2.45%
2024/11/0400.001561.2761.90-15293-5.12%
2024/11/0100.001061.2560.60-10298-3.35%
2024/10/3000.001260.9860.30-12305-3.93%
2024/10/2900.00161.2061.00-1308-0.32%
2024/10/2800.001061.5061.60-10313-3.19%
2024/10/2500.001863.0762.50-18313-5.75%
2024/10/2400.004964.8063.90-49314-15.60%
2024/10/2300.001563.4062.80-15311-4.82%
2024/10/2200.003163.5463.50-31313-9.88%
2024/10/2100.005663.6463.40-56318-17.58%
2024/10/1800.002262.3862.00-22322-6.83%
2024/10/1700.002264.2563.40-22322-6.82%
2024/10/1600.002164.0763.20-21324-6.46%
2024/10/1500.00163.6063.20-1326-0.31%
2024/10/1400.001165.0064.60-11328-3.35%
2024/10/1100.002565.6264.80-25328-7.60%
2024/10/0900.001666.2464.60-16328-4.88%
2024/10/0800.004167.8366.00-41328-12.48%
2024/10/071169.406869.0068.00-57324-17.55%
2024/09/3000.001566.2565.00-15293-5.11%
2024/09/26462.5800.0061.6042911.37%
2024/09/20165.8000.0064.6012950.34%
2024/09/1900.00465.8566.00-4294-1.36%
2024/09/1200.001364.5564.20-13294-4.41%
2024/09/10264.0000.0063.4022970.67%
2024/09/03866.10464.0064.2042881.39%
2024/09/02464.4500.0066.0042891.38%
2024/08/2800.001059.2559.40-10279-3.58%
2024/08/2700.00759.7160.00-7278-2.51%
2024/08/26761.301060.5560.50-3277-1.08%
2024/08/2300.003464.8961.50-34274-12.40%
2024/08/2200.003066.9066.90-30251-11.93%
2024/08/20555.4800.0055.4052511.98%
2024/08/19556.1000.0056.4052511.99%
2024/08/16258.304857.6257.00-46251-18.32%
2024/08/151055.9600.0056.70102533.95%
2024/08/1300.002052.0251.20-20275-7.26%
2024/08/0900.002050.4252.00-20275-7.26%
2024/08/07251.40551.3451.70-3281-1.07%
2024/08/06349.0500.0049.9532781.08%
2024/08/0100.001557.2558.30-15269-5.56%
2024/07/2900.002057.6357.10-20267-7.48%
2024/07/22061.1000.0060.8002880.00%
2024/06/2700.001072.4074.00-10380-2.63%
2024/06/2600.00270.9070.00-2403-0.50%
2024/06/2500.00770.8170.00-7438-1.60%
2024/06/2400.00770.6670.50-7452-1.55%
2024/06/2100.003970.0369.60-39456-8.55%
2024/05/2400.001076.7576.80-10823-1.21%
2024/05/23277.0000.0077.0028300.24%
2024/05/2000.008078.7282.00-80849-9.42%
2024/05/1700.002076.0975.90-20863-2.32%
2024/04/25164.50066.8065.3019320.10%
2024/04/2400.001468.7467.80-14922-1.52%
2024/04/18270.005770.0569.00-55909-6.04%
2024/04/1600.001072.0071.70-10905-1.10%
2024/04/0900.00180.5080.20-1863-0.12%
2024/04/0100.0023082.8986.90-230835-27.51% 大賣/鉅額交易
2024/03/29380.006280.0380.00-59813-7.25%
2024/03/281486.16185.0083.10137871.65%
國邑*吸入新藥完成澳洲一期臨床 預計年底完成與美國FDA Pre-IND會議Anue鉅亨-2024/10/23
國邑* 相關文章
國邑* 相關影音